- Developing a strategic and operational plan for iCAIRD.
- Ensuring the programme of work is on track.
- Reviewing new project submissions for consideration by iCAIRD.
- Identifying and engaging with new funding opportunities.
- Ensuring appropriate project governance is in place, particularly in relation to handling of sensitive patient data.
Professor Dame Anna F Dominiczak
Professor Dame Anna Dominiczak DBE, MD, FRCP, FAHA, FRSE, FMedSci is Regius Professor of Medicine, Vice Principal and Head of the College of Medical, Veterinary and Life Sciences at the University of Glasgow as well as honorary consultant physician and non-executive member of NHS Greater Glasgow and Clyde Health Board. In 2016, she was awarded a DBE for services to cardiovascular and medical science.
Professor Dominiczak is one of the world’s leading cardiovascular scientists and clinical academics. She held a British Heart Foundation Chair of Cardiovascular Medicine at the University of Glasgow between 1997 and 2010, and directorship of the Cardiovascular Research Centre between 2000 and 2010. Her major research interests are in hypertension, cardiovascular genomics and precision medicine, where she not only publishes extensively in top peer-reviewed journals (over 400 publications), but also excels in large-scale research funding for programmes and infrastructure (with a total value in excess of £100M over the last seven years). She leads a collaboration of four universities, four academic NHS Health Boards across Scotland and two major industry partners in a public/private partnership focused on precision medicine, with a value in excess of £20M.
Professor Dominiczak is a Fellow of the Royal College of Physicians, the American Heart Association, the Academy of Medical Sciences, the Royal Society of Edinburgh, the European Society of Cardiology and the Society of Biology. She is a member of the British Medical Association, British Hypertension Society, European Society of Hypertension, International Society of Hypertension, British Endocrine Society, Association of Physicians of Great Britain and Ireland, American Physiological Society, British Atherosclerosis Society, British Cardiovascular Society and European Atherosclerosis Society. From 2013 to 2015, she was President of the European Society of Hypertension.
Professor David Harrison
David Harrison MD, DSc, FRCPath, FRCPEd, FRCSEd graduated from the University of Edinburgh and trained as a histopathologist. Whilst clinically specialising in liver and kidney, his research interests are broader, coming under the general banner of systems biology and AI applied to pathology. He is currently Professor of Pathology in St Andrews, and Director of Development for Laboratory Medicine in NHS Lothian. David holds honorary chairs in Glasgow, Florida, Edinburgh, the last of these where he was Professor of Pathology for 12 years and Director of the Edinburgh Cancer Research Centre. Alongside his clinical and academic work, David is director in several small biotech companies, he chairs the UK Committee on Carcinogenicity and is Chairperson of numerous charities. He is Director of iCAIRD (Industrial Centre for AI Research in Digital Diagnostics), a Scotland-wide consortium funded by Innovate UK.
Professor Corri Black
Professor Corri Black trained at the University of Glasgow graduating in 1996 and spent 5 years working in hospital medicine in Glasgow. She spent a year at the Boston Collaborative Drug Surveillance Programme, University of Boston, USA on a Research Scholarship studying Clinical and Pharmacoepidemiology. On return to the UK, she joined the University of Aberdeen as a Clinical Lecturer in 2002 and completed specialist training in Public Health Medicine before being appointed as a Senior Clinical Lecturer in Public Health and Honorary NHS Consultant in 2007. She was awarded a personal Chair in 2015.
Professor Corri Black is a Co-Director of the Aberdeen Centre for Health Data Science, Deputy Director of Farr Institute@Scotland, Associate Director of HDRUK@Scotland and has 18 years experience of harnessing electronic health record data for research. As a Consultant in Public Health, she works for NHS Grampian supporting the use of data to drive quality improvement and in population health surveillance. She is the Clinical Lead for the Grampian Data Safe Haven. Working with colleagues, her research has included real world data pharmaceutical research and now focuses on understanding complexity in health in long term conditions and across the life course. She currently serves as the Grampian Safe Haven Academic Lead for iCAIRD.
Professor Alison Murray
Professor Alison Murray MBChB (Hons), MRCP, FRCR, PhD, FRSE is the Roland Sutton Professor of Radiology at the University of Aberdeen. She is Director of the Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE) a brain imaging pooling initiative, an executive member of the Scottish Dementia Research Consortium and past-president of the Scottish Radiological Society. She leads NHS molecular brain imaging in people with neurodegenerative diseases and dementia. She has a track record of brain magnetic resonance imaging research in the Aberdeen Birth Cohorts on factors that increase risk of cognitive impairment and conversely, what provides resilience to decline. She is passionate about the influence of early-life socioeconomic circumstance on late-life brain health. Professor Murray currently serves as Radiology Expert for the Board.
Dr David Stirling
Dr Stirling serves as the NSS representative on the Board.
Dr Gareth Bryson
Dr Gareth Bryson is a consultant pathologist at the Queen Elizabeth University Hospital, where he has also held the role of Head of Service for Pathology since 2016. Gareth’s areas of expertise include gynaecological and urological pathology. His non-clinical interests include efficient systems, laboratory modernisation and workload measurement and digital pathology. He is the Scottish Lead for Digital Pathology. Within iCAIRD, Gareth is leading on the full digitisation of NHS GGC Pathology within the lifetime of the programme. He is also contributing to the exemplar projects with colleagues from University of St Andrews and Philips. He currently serves as Pathology Expert on the Governance Board.
Professor Julie Brittenden
Professor Julie Brittenden graduated from the University of Aberdeen in 1988 and obtained a Doctor of Medicine with honours in 1995. She has worked in Aberdeen & Edinburgh before moving to Glasgow in 2015. Julie is Professor of Vascular Surgery at Glasgow University, Director of Research & Development for NHS GGC and Director of the joint Glasgow University & NHS GGC Clinical Research Facilities.
Her research interests include cardiac risk factor management & novel biomarkers in patients with peripheral arterial disease; evaluating and imaging of unstable carotid plaques. She is Chief Investigator of RCTs of innovative venous therapies and devices to improve physical activity in patients with PAD.
Julies' current responsibilities include membership of the following; Management board for NHS Research Scotland, the NRS oversight Board Health Science Scotland, Life Sciences Scotland Industry Leadership Group and Scottish Health Innovations Ltd, in addition to the NIHR HTA General Board Panel & Venous Forum Council. She is specialists advisor to the Scottish Medicines Consortium (2003-present) and reviewer for the Scottish health Technology Group.
Julie serves a dual role as Data Officer/ Glasgow Safe Haven Academic Lead for iCAIRD on the Governance Board.
Professor Mark Parsons
Professor Mark Parsons holds a Personal Chair in High Performance Computing at the University of Edinburgh. He is the Director of EPCC, the University of Edinburgh’s supercomputing centre, a position he has held since 2016. He is also the Associate Dean for e-Research in the College of Science and Engineering, a role he has held since 2010. Professor Parsons joined EPCC following his PhD at CERN in 1994 to work as a software developer.
Ken Sutherland is President of Canon Medical Research Europe. He is a Director on Canons’ Board and responsible for all aspects of the strategic development and operational control within Canon Medical Research Europe Ltd and is also a key member of Canon Medical Systems Global R&D leadership team.
He serves as a member of the Scottish Government Inward Investment Forum, a lay member of the Court of Glasgow University and as an advisory board member of the Scottish Lifesciences Association. He was recently admitted as a Fellow of the Royal Society of Edinburgh.
Ken studied Electronics and Computer Science at Edinburgh University and gained a PhD in image analysis and four years postdoctoral research experience in medical image analysis. He returned to Edinburgh in August 2007 to join Canon Medical as R&D General Manager following his previous post of Operations Director for a European multinational where he was responsible for their imaging R&D facility in Cambridge, England. Ken currently serves as the Canon core partner representative on the iCAIRD Governance Board.
Andy Smout is Vice President, Research at Canon Medical Research Europe, with overall responsibility for technology research, advanced development, intellectual property and software architecture. He has extensive experience in designing, building and supporting large scale software systems and has recently been responsible for the establishment of Canon Medical’s global Centre of Excellence for Artificial Intelligence in Edinburgh.
After gaining his PhD in Quantum Electronics from the University of Essex, Andy worked in factory process control and semiconductor lithographic overlay metrology before joining Canon Medical in 2000. He worked for many years as Technical Lead of the Custom Solutions division, and following a brief period as Engineering Manager for Voxar 3D he transitioned to Chief Architect in 2007, Group Leader of Infrastructure in 2010, and finally Vice President for Research in 2013. Andy has been awarded a number of patents; however his proudest achievement was to have a seminal paper on “Mutually Incoherent Beam Coupling in BaTiO32” published in 1987, which has now received 142 citations. He currently serves on the Governance Board as the second Canon representative.
Nimish currently serves as the Philips core partner representative on the iCAIRD Governance Board.
William was appointed as the Director of eHealth at NHS Greater Glasgow and Clyde in July 2017, having been the Interim Director since November 2016. He has held a number of senior national and local ICT roles since joining the NHS in June 1999. He was formerly the Head of eHealth at the NHS Scotland NWTC Board/Golden Jubilee Hospital and General Manager - eHealth at NHS Fife before joining NHS Greater Glasgow and Clyde.